Review of incidence studies of tardive dyskinesia associated with typical antipsychotics

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 4, 2000, Pages 15-20

  Glazer, William M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DISEASE COURSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POPULATION RISK; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; RISK FACTOR; TARDIVE DYSKINESIA;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PSYCHOTIC DISORDERS; RESEARCH DESIGN; RISK FACTORS; SCHIZOPHRENIA;

EID: 0034023921     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Glazer WM, Morgenstern H, Doucette JT. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. J Clin Psychiatry 1993;54:133-139
2. Morgenstern H, Glazer WM. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications: results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 1993;50: 723-733
3. Glazer W, Morgenstern H. Predictors of occurrence, severity and course of tardive dyskinesia in an outpatient population. J Clin Psychopharmacol 1988;8(4. suppl):10S-16S
4. Gardos G, Cole JO. Overview: public health issues in tardive dyskinesia. Am J Psychiatry 1980;137:776-781
5. Gibson AC. Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection. Acta Psychiatr Scand 1981;63:111-116
6. Kane JM, Woerner M, Weinhold P, et al. A prospective study of tardive dyskinesia development: preliminary results. J Clin Psychopharmacol 1982;2: 345-349
7. Kane JM, Woerner M, Weinhold P, et al. Incidence of tardive dyskinesia: five-year data from a prospective study. Psychopharmacol Bull 1984;20: 387-389
8. Yassa R, Nair V. Incidence of tardive dyskinesia in an outpatient population. Psychosomatics 1984;25:479-481
9. Chouinard G, Annable L, Mercier P, et al. A five-year follow-up study of tardive dyskinesia. Psychopharmacol Bull 1986;22:259-263
10. Chouinard G, Annable L, Ross-Chouinard A, et al. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. J Clin Psychopharmacol 1988;8(4, suppl):21S-26S
11. Gardos G, Perenyi A, Cole JO, et al. Seven-year follow-up of tardive dyskinesia in Hungarian outpatients. Neuropsychopharmacology 1988;1: 169-172
12. Waddington JL, Youssef HA, Kinsella A. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med 1990;20:835-842
13. Inada T, Ohnishi K, Kamisada M, et al. A prospective study of tardive dyskinesia in Japan. Eur Arch Psychiatry Clin Neurosci 1991;240:250-254
14. Chakos MH, Alvir JMJ, Woerner MG, et al. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry 1996;53:313-319
15. Woerner MG, Alvir JMJ, Saltz BL, et al. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998;155: 1521-1528
16. Paulsen JS, Caligiuri MP, Palmer B, et al. Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study. Psychopharmacology 1996;123:307-314
17. Caligiuri MP, Lacro JP, Rockwell E, et al. Incidence and risk factors for severe tardive dyskinesia in older patients. Br J Psychiatry 1997;171: 148-153
18. Jeste DV, Lacro JP, Palmer B, et al. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry 1999;156:309-311
19. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia [letter]. Arch Gen Psychiatry 1982;39:486-487
20. Yassa R, Jeste DV. Gender as a factor in the development of tardive dyskinesia. In: Yassa R, Nair NPV, Jeste DV, eds. Neuroleptic-Induced Movement Disorders. New York, NY: Cambridge University Press; 1997: 26-40
21. Jeste DV, Caligiuri MP, Paulsen JS, et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 1995;52:756-765
22. Crane GE. Pseudoparkinsonism and tardive dyskinesia. Arch Neurol 1972;27:426-430
23. Kane JM, Woerner M, Borenstein M, et al. Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 1986;22:254-258
24. Chatterjee A, Chakos M, Koreen A, et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 1995;152:1724-1729